71627-22-0 Usage
General Description
Pipermethystine is a chemical compound that belongs to the category of phenethylamine derivatives. It is a structural analog of the stimulant drug MDMA (ecstasy) and shares similar psychoactive properties. Pipermethystine is known to act as a releasing agent for serotonin, dopamine, and norepinephrine, leading to increased levels of these neurotransmitters in the brain. It has been studied for its potential use in the treatment of conditions such as depression and anxiety, as well as for its use as a recreational drug. However, pipermethystine has not been approved for medical use and is a controlled substance in many countries due to its potential for abuse and addiction. Studies on its safety and efficacy are ongoing, and it is important to use caution and discretion when considering its use.
Check Digit Verification of cas no
The CAS Registry Mumber 71627-22-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,6,2 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 71627-22:
(7*7)+(6*1)+(5*6)+(4*2)+(3*7)+(2*2)+(1*2)=120
120 % 10 = 0
So 71627-22-0 is a valid CAS Registry Number.
InChI:InChI=1/C16H17NO4/c1-12(18)21-14-8-10-16(20)17(11-14)15(19)9-7-13-5-3-2-4-6-13/h2-6,8,10,14H,7,9,11H2,1H3
71627-22-0Relevant articles and documents
Facile enantiodivergent approach to 5-hydroxy-5,6-dihydro-2(1H)-pyridones. First total synthesis of both enantiomers of pipermethystine.
Arrayas,Alcudia,Liebeskind
, p. 3381 - 3383 (2007/10/03)
[reaction: see text]. A novel enantiodivergent approach to 5-hydroxy-5,6-dihydro-2(1H)-pyridones using a ring closing metathesis and a lipase-mediated kinetic resolution as key steps is described and applied to the first synthesis of both enantiomers of pipermethystine.
